Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

QuidelOrtho Corporation - Common Stock (NQ: QDEL )

44.84 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation
The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation 
Via News Direct
Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference
From Quidel Corporation
Via Business Wire
Bulls Should Begin 2022 With A Win
The first trading day of the new year is seasonally very strong by a number of studies and that is reinforced by the late day weakness to end 2021. 
Via Talk Markets
Three Stocks To Buy Now For 2022
Some investors thought it would never get here, but the 
Via Talk Markets
Quidel’s Antigen Tests Detect the Omicron Variant
From Quidel Corporation
Via Business Wire
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65. The U.S. has the... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pasithea Therapeutics (NASDAQ: 
Via Benzinga
Quidel (QDEL) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Quidel Corporation is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – QDEL
From Halper Sadeh
Via Business Wire
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion. 
Via InvestorPlace
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
Midway through trading Thursday, the Dow traded up 0.62% to 35,975.34 while the NASDAQ rose 0.66% to 15,624.94. The S&P also rose, gaining 0.67% to 4,728.06. The U.S. has the... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK.... 
Via Benzinga
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
Stock index futures point higher as investors look to add to two days of gains. Thursday is the last trading day of the week because markets are closed on Friday in observance of... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in... 
Via Benzinga
Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
From Quidel Corporation
Via Business Wire
Free COVID Tests: What Stocks Will Benefit?
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
Via Talk Markets
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022. 
Via Talk Markets
COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests
President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to... 
Via Benzinga
QDEL Stock Alert: What Is Going on With Quidel Today?
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result. 
Via InvestorPlace
Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks
From Quidel Corporation
Via Business Wire
Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease
From Quidel Corporation
Via Business Wire
Biotech Playbook 2021: No Help From Small Caps In Q4
Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but... 
Via Talk Markets
7 Stocks to Buy to Hedge Against Omicron Variant Risks
With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD 
Via Benzinga
The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir... 
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Quidel Statement on the Omicron Variant
From Quidel Corporation
Via Business Wire
Biotech Stocks are Due for a Rally
There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums. 
Via Talk Markets
Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference
From Quidel Corporation
Via Business Wire
Looking for Growth in Small and Mid Cap Life Science Stocks
2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps. 
Via Talk Markets
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.